Intco Medical Technology Co (300677) Fair Value & Analysis
Healthcare · CN · Market cap 27.4B CNY
Fair value as of: Jul 9, 2026
From 14 valuation models · updated 32 days ago
Share price +10.8% over the past month.
Below-average quality, and screening another 48% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥32.80). The favourable scenario is already priced in.
- Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.
How to read this chart
60‑month range ¥17.53 – ¥122.21 · fair‑value band ¥22.42 – ¥32.80 · the ¥50.54 price screens above the ¥26.24 fair value. Dashed = 300-day average. As of Jul 9, 2026.
Analysis
Intco Medical Technology Co (300677) currently trades at ¥50.54, while our model-based Fair Value estimate is ¥26.24, implying the stock looks roughly 48.1% overvalued today. The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Intco Medical Technology Co generated revenue of 10.3B CNY at a net margin of 6.5%. Revenue grew 15.8% year over year. It earns a return on equity of 3.8%. Net debt stands at 10.9B CNY. Fundamentals as of Jul 9, 2026
Our scenario range runs from ¥22.42 (bear case) to ¥32.80 (bull case); at ¥50.54, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 26% below its 52-week high and 120% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside, at -48%, 300677 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Growth Earnings (¥56.67) versus Asset-Based (¥18.68). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 43 · Market factors (momentum, volatility) 69
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care for medical and elderly care institutions, household daily use, and other related industries in China and internationally.
Full company description
Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care for medical and elderly care institutions, household daily use, and other related industries in China and internationally. The company offers disposable gloves, gowns, apparel, face masks, diaper, pad, wipes, non-woven sundries, PE products, and hand hygiene; wheelchair, scooter, rollator, lift, and others; physical therapy hot and cold therapy, sport and outdoor, pet products, patient monitoring, and electrosurgery. It also provides ECG electrode, such as monitoring ECG, stress test and holter, diagnostic ECG, pre-wired neonatal, repositionable, tens, off-set ECG, and defibrillation electrode; grounding pad, electrosurgical pencil, and feminine care. The company was formerly known as Intco Medical Technology Co., Ltd. and changed its name to Intco Medical Technology Co., Ltd. in January 2020. Intco Medical Technology Co., Ltd. was founded in 2009 and is headquartered in Zibo, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Intco Medical Technology Co reported revenue of ¥9.9B in FY2025 versus ¥16.2B in FY2021, a compound −11.6%/yr. Reported net income was ¥1.0B in FY2025, compounding −39.3%/yr from FY2021.
300677 screens 48% overvalued. Compare with Intuitive Surgical, Inc →
Peer Group
Medical Instruments & Supplies · 203 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.33 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €172.45 | €68.55 | -60% |
| Medline Inc MDLN | $41.11 | $30.15 | -27% |
| Becton, Dickinson and Company BDX | $150.65 | $103.53 | -31% |
| Alcon Inc ALC | $70.26 | $39.78 | -43% |
| ResMed Inc RMD | $203.87 | $187.89 | -8% |
| West Pharmaceutical Services, Inc WST | $353.71 | $143.97 | -59% |
| Straumann Holding STMN | CHF 106.00 | CHF 47.31 | -55% |
| Sartorius Stedim Biotech S.A DIM | €188.50 | €51.16 | -73% |
| Coloplast A/S COLOB | kr 414.00 | kr 382.22 | -8% |
Compare Intco Medical Technology Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Intco Medical Technology Co (300677) overvalued or undervalued?
What is the fair value of 300677?
What is the quality score of 300677?
What is the revenue of Intco Medical Technology Co (300677)?
What is the net profit margin of 300677?
Does Intco Medical Technology Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Intco Medical Technology Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.